Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders.
Persons presenting with concurrent psychiatric and substance problems present unique challenges for diagnosis and for effective and rational treatment planning. This is especially true for psychiatrists attempting to prescribe pharmacologic interventions which will promote recovery from both disorders and improve function. In order to be effective in this endeavor it is important to have a clear understanding of the dynamics of addiction as well as the particular issues and struggles related to mental illness which will affect an individual's attitude toward and use of medication. This article discusses some of the common problems related to diagnostic decision making and initiation of medication in persons with co-occurring disorders. An algorithm for guiding these decisions is presented. Common misconceptions held by these individuals regarding medication, as distinguished from "drugs," are considered. Unique psychodynamic issues that may lead these persons to actively seek medication as a solution to their problems, or which may, conversely, lead them to an outright rejection of medication as a part of their recovery, are discussed. Countertransferential issues influencing the physician's approach to prescribing for this population are also considered. The article concludes with recommendations for pharmacologic approaches to address specific psychiatric syndromes which may present in this population.
Sowers
W
W
Center for Addiction Services, St. Francis Medical Center, Pittsburgh, Pennsylvania 15201, USA.
Golden
S
S
D017831:Diagnosis, Dual (Psychiatry) / Q000523:psychology; D006801:Humans; D008509:Medication Systems; D001523:Mental Disorders / Q000175:diagnosis* / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000628:therapy
D011619:Psychotropic Drugs